INDIES Stock Overview
Engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Indies Pharma Jamaica Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JA$2.94 |
| 52 Week High | JA$3.44 |
| 52 Week Low | JA$2.25 |
| Beta | 0.41 |
| 11 Month Change | -0.68% |
| 3 Month Change | 17.60% |
| 1 Year Change | 5.38% |
| 33 Year Change | -2.00% |
| 5 Year Change | -5.16% |
| Change since IPO | -6.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| INDIES | JM Healthcare | JM Market | |
|---|---|---|---|
| 7D | -2.0% | -1.1% | 1.3% |
| 1Y | 5.4% | -2.7% | 5.7% |
Return vs Industry: INDIES exceeded the JM Healthcare industry which returned -2.7% over the past year.
Return vs Market: INDIES matched the JM Market which returned 5.7% over the past year.
Price Volatility
| INDIES volatility | |
|---|---|
| INDIES Average Weekly Movement | 7.1% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in JM Market | 16.4% |
| 10% least volatile stocks in JM Market | 4.4% |
Stable Share Price: INDIES has not had significant price volatility in the past 3 months compared to the JM market.
Volatility Over Time: INDIES's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 71 | Guna Muppuri | www.indiespharma.com |
Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. It offers prescription and over the counter drugs in tablet, topical creams, ointment, suspension, injection, capsule, sachet and dispersible tablet, oral mixture, cream, solution, gel, shampoo, drop, chewable tablet, syrup, nasal spray, vaginal cream and pessary, tonic, and oral powder and solution dosage forms. The company provides its products for use as cardiovascular agents, including anti-hypertensive, circulation and anti-thrombotic, anti-cholesterol, venous circulation and hemorrhoids, gastro-intestinal, antibiotic, anti-diabetes, and antiviral agents.
Indies Pharma Jamaica Limited Fundamentals Summary
| INDIES fundamental statistics | |
|---|---|
| Market cap | JA$3.92b |
| Earnings (TTM) | JA$215.57m |
| Revenue (TTM) | JA$1.14b |
18.2x
P/E Ratio3.4x
P/S RatioIs INDIES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INDIES income statement (TTM) | |
|---|---|
| Revenue | JA$1.14b |
| Cost of Revenue | JA$464.40m |
| Gross Profit | JA$671.40m |
| Other Expenses | JA$455.83m |
| Earnings | JA$215.57m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 59.11% |
| Net Profit Margin | 18.98% |
| Debt/Equity Ratio | 65.0% |
How did INDIES perform over the long term?
See historical performance and comparison